• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Use of pregabalin may increase risk of heart failure in geriatric patients

bySimon PanandAlex Chan
August 10, 2025
in Cardiology, Chronic Disease, Neurology, Pharma
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In patients aged 65 to 89 years of age with non-cancer chronic pain, use of pregabalin was associated with an increased risk of developing heart failure (HF) compared with gabapentin. 

Evidence Rating Level: 2 (Good)

Pregabalin and gabapentin are commonly prescribed medications for the management of chronic pain. While both medications may be associated with cardiovascular adverse effects based on limited reports, existing studies have limited their analyses to neurological indications or have not focused on older adults. This retrospective cohort study therefore sought to investigate the incidence of HF in older adults using pregabalin compared with gabapentin. 246,237 patients (median age[IQR], 73[69-78] years; 66.8% female) aged 65 to 89 years of age receiving pregabalin or gabapentin for chronic pain without a history of HF from the United States were included in this study. The primary endpoint was hospitalization or ED visit with a diagnosis of HF, with secondary endpoints including a diagnosis of HF in the outpatient setting. The incidence of HF with pregabalin was 18.2 (95% CI, 15.3-21.6) per 1000 person-years compared to 12.5 (95% CI, 11.9-13.2) per 1000 person-years for gabapentin, with a corresponding adjusted hazard ratio (AHR) for pregabalin vs gabapentin of 1.48 (95% CI, 1.19-1.77). Additionally, there was a higher incidence of outpatient diagnosis of HF in patients receiving pregabalin compared to gabapentin (AHR, 1.27 [95% CI, 1.02-1.58]). Overall, this study found that among older patients with non-cancer chronic pain, management with pregabalin was associated with higher risk of HF compared with gabapentin. 

Click to read the study in JAMA Network Open

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

RELATED REPORTS

Steroidal mineralocorticoid receptor antagonists show little mortality benefit in patients receiving dialysis

Corstasis’ Enbumyst nasal spray approved for edema

Spironolactone does not reduce cardiovascular events in patients receiving maintenance dialysis

Tags: cardiologygabapentinoidsheart failurepharmacologypregabalin
Previous Post

Antiseizure medications do not reduce the risk of epilepsy in patients with brain abscess

Next Post

2 Minute Medicine Rewind August 11, 2025

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Steroidal mineralocorticoid receptor antagonists show little mortality benefit in patients receiving dialysis

September 18, 2025
Variation noted across pre- and post-marketing studies for FDA approved devices
Pharma

Corstasis’ Enbumyst nasal spray approved for edema

September 18, 2025
Fish oil and aspirin did not reduce arteriovenous fistula failure: The FAVOURED trail
Cardiology

Spironolactone does not reduce cardiovascular events in patients receiving maintenance dialysis

September 17, 2025
Neurocognitive deficits in congenital heart disease may not worsen with age
AI Roundup

Artificial intelligence stethoscope detects heart disease in seconds

September 16, 2025
Next Post

2 Minute Medicine Rewind August 11, 2025

High incidence of foreskin morbidity in uncircumcised males

Post-operative pain scores may be a predictor of 30-day infectious and non-infectious post-operative complications

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Sleep quality patterns may predict outcomes in patients with heart failure:

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial
  • How Long Is the MCAT and Why It Matters for Test-Takers
  • 2 Minute Medicine Rewind September 22, 2025
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.